EFSD Partners



Over Euro 50 million for diabetes research in Europe

On behalf of EASD members, EFSD wishes to acknowledge and thank its partners for their generous support and outstanding contribution to European diabetes research:

Amylin Pharmaceuticals Inc.
GlaxoSmithKline (GSK)
Juvenile Diabetes Research Foundation (JDRF)
LifeScan
Lilly
Merck Sharp & Dohme (MSD)
Novartis Pharma AG
Novo Nordisk A/S
Pfizer Inc.
sanofi-aventis Group